{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:04:21Z","timestamp":1792839861117,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T00:00:00Z","timestamp":1450051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00415-015-7983-1","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T10:17:16Z","timestamp":1450088236000},"page":"370-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Isolated new onset \u2018atypical\u2019 optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up"],"prefix":"10.1007","volume":"263","author":[{"given":"L.","family":"Piccolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jury\u0144czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. I.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"issue":"5","key":"7983_CR1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53(5):1107\u20131114","journal-title":"Neurology"},{"issue":"4","key":"7983_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4water channel. J Exp Med 202(4):473\u2013477","journal-title":"J Exp Med"},{"key":"7983_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1759-1961.2012.00030.x","volume":"3","author":"K Fujihara","year":"2012","unstructured":"Fujihara K, Misu T, Nakashima I et al (2012) Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease. Clin Exp Neuroimmunol 3:58\u201373","journal-title":"Clin Exp Neuroimmunol"},{"issue":"9","key":"7983_CR4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"7983_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","volume":"298","author":"S Jarius","year":"2010","unstructured":"Jarius S, Frederikson J, Waters P et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298(1\u20132):158\u2013162","journal-title":"J Neurol Sci"},{"issue":"8","key":"7983_CR6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","volume":"84","author":"A Jacob","year":"2013","unstructured":"Jacob A, McKeon A, Nakashima I et al (2013) Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 84(8):922\u2013930","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"7983_CR7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1177\/1352458514546517","volume":"20","author":"G Arrambide","year":"2014","unstructured":"Arrambide G, Rovira A, Tur C, Montalban X (2014) NMO spectrum disorders: how wide is the spectrum? Mult Scler 20(10):1417\u20131419","journal-title":"Mult Scler"},{"issue":"7","key":"7983_CR8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF et al (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63(7):964\u2013968","journal-title":"Arch Neurol"},{"issue":"5","key":"7983_CR9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1191\/1352458505ms1200cr","volume":"11","author":"AY Poppe","year":"2005","unstructured":"Poppe AY, Lapierre Y, Melan\u00e7on D et al (2005) Neuromyelitis optica with hypothalamic involvement. Mult Scler 11(5):617\u2013621","journal-title":"Mult Scler"},{"issue":"pt 5","key":"7983_CR10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Fujihara K, Nakashima I et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130(pt 5):1235\u20131243","journal-title":"Brain"},{"issue":"7","key":"7983_CR11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","volume":"65","author":"P Waters","year":"2008","unstructured":"Waters P, Jarius S, Littleton E et al (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65(7):913\u2013919","journal-title":"Arch Neurol"},{"issue":"9","key":"7983_CR12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI et al (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78(9):665\u2013671 (discussion 669. 6)","journal-title":"Neurology"},{"issue":"11","key":"7983_CR13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","volume":"70","author":"J Kitley","year":"2013","unstructured":"Kitley J, Leite MI, K\u00fcker W et al (2013) Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol 70(11):1375\u20131381","journal-title":"JAMA Neurol"},{"issue":"7","key":"7983_CR14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Asgari N, Apiwattanakul M et al (2015) Demographic and clinical features of neuromyelitis optica: a review. Multi Scler J 21(7):845\u2013853 (Review)","journal-title":"Multi Scler J"},{"issue":"11","key":"7983_CR15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"12","key":"7983_CR16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79(12):1273\u20131277","journal-title":"Neurology"},{"issue":"3","key":"7983_CR17","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2(3):e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"7983_CR18","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"issue":"23","key":"7983_CR19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello M, Lennon VA, Jacob A et al (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70(23):2197\u20132200 (epub 2008 Apr 23)","journal-title":"Neurology"},{"issue":"4\u20135","key":"7983_CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.autrev.2014.01.009","volume":"13","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT (2014) Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev 13(4\u20135):539\u2013545 (epub 2014 Jan 12)","journal-title":"Autoimmun Rev"},{"issue":"6","key":"7983_CR21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","volume":"115","author":"Optic Neuritis Study Group","year":"2008","unstructured":"Optic Neuritis Study Group (2008) Visual function 15\u00a0years after optic neuritis: a final follow-up report from the optic neuritis treatment trial. Ophthalmology 115(6):1079\u20131082 (e5)","journal-title":"Ophthalmology"},{"issue":"1","key":"7983_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","volume":"261","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT (2014) Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 261(1):17\u201326","journal-title":"J Neurol"},{"key":"7983_CR23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","volume":"135","author":"J Kitley","year":"2012","unstructured":"Kitley J, Leite MI, Nakashima I et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 135:1834\u20131849","journal-title":"Brain"},{"issue":"8","key":"7983_CR24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T (2013) The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9(8):455\u2013461 (Review)","journal-title":"Nat Rev Neurol"},{"key":"7983_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","volume":"13","author":"KC O\u2019Connor","year":"2007","unstructured":"O\u2019Connor KC, McLaughlin KA, De Jager PL et al (2007) Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13:211\u2013217","journal-title":"Nat Med"},{"issue":"12","key":"7983_CR26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79(12):1273\u20131277","journal-title":"Neurology"},{"issue":"3","key":"7983_CR27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71(3):276\u2013283","journal-title":"JAMA Neurol"},{"issue":"6","key":"7983_CR28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82(6):474\u2013481","journal-title":"Neurology"},{"issue":"4","key":"7983_CR29","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","volume":"1","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Reddel SW, Henderson A et al (2014) Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 1(4):e40","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"7983_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","volume":"72","author":"E Martinez-Hernandez","year":"2015","unstructured":"Martinez-Hernandez E, Sepulveda M, Rost\u00e1sy K et al (2015) Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor \u03b11 subunit in patients with isolated optic neuritis. JAMA Neurol 72(2):187\u2013193","journal-title":"JAMA Neurol"},{"key":"7983_CR31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","volume":"66","author":"F Brilot","year":"2009","unstructured":"Brilot F, Dale RC, Selter RC et al (2009) Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 66:833\u2013842","journal-title":"Ann Neurol"},{"key":"7983_CR32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Probstel","year":"2011","unstructured":"Probstel AK, Dornmair K, Bittner R et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580\u2013588","journal-title":"Neurology"},{"key":"7983_CR33","doi-asserted-by":"crossref","unstructured":"Baumann M, Sahin K, Lechner C et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatr (epub 2014 Aug 13)","DOI":"10.1136\/jnnp-2014-308346"},{"issue":"7","key":"7983_CR34","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","volume":"21","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, Sepulveda M, Armangue T et al (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21(7):866\u2013874","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7983-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7983-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7983-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7983-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T12:52:27Z","timestamp":1567428747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7983-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,14]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["7983"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7983-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,14]]}}}